Catch up on the top radiology content of the past week ..read more

The combination of Philips’ MR 7700 multi-nuclei scanner with the FDA-approved Xenoview hyperpolarized Xenon magnetic resonance imaging (MRI) contrast agent may facilitate earlier diagnosis and intervention for patients with obstructive lung diseases ..read more

The artificial intelligence (AI)-powered Ezra Flash reportedly enhances magnetic resonance imaging (MRI) and enables significant reductions in scan times and costs for full-body MRI ..read more

Catch up on the top five most viewed content at Diagnostic Imaging for the month of May 2023 ..read more

In a large retrospective study involving over 523,000 digital breast tomosynthesis (DBT) exams and over one million digital mammography (DM) exams, researchers found that DBT was associated with significantly lower recall rates but showed no advantage over DM in the diagnosis of interval or advanced breast cancer ..read more

Precision DL, a deep learning-based software which will be available on GE HealthCare’s Omni Legend PET/CT device, reportedly increases the detectability of small, low-contrast lesions by 42 percent ..read more

Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum prostate-specific antigen (PSA) level ..read more

Review the case study and test your knowledge to make the correct diagnosis ..read more

Photon-counting computed tomography (PCCT) significantly increased the signal-to-noise ratio (SNR) and the contrast-to-noise ratio (CNR) in comparison to dual-source CT (DSCT) at similar radiation dosing, according to a new study of over 100 children with suspected congenital heart defects ..read more

Catch up on the top radiology content of the past week ..read more